1. For the legal bods out there why doesn't this need shareholder approval? 2. I want to see the beneficial owners of this fund, I cannot understand david diluting at this level unless there are such r and d opportunities with a short term massive payback 3. This is currently priced with a very high expectation that it is not a going concern, at least this is off the table
Hi dj, too quick out the blocks. Good for me as I have some dividends coming in tomorrow in my sipp to get some at a lower price. This is a long term buy over 3-4 years, buy on any short term weakness and just hold rather than trade.
Tracy, when we get the 20p warrants do you for see selling, tracking back down to 16/17p - alternatively some blow out news which just blows this out the water? Surprised we have an overhang of shares, as a miton microcap shareholder pretty pi#### that they are selling at this level - I think they don't want to have this as a shareholding from much higher levels.
Hi esh, I'm happy with a 500% growth rate - just extrapolate this over another two years and you are at 18-19 million for the half year. With a relatively fixed cost base and sunk costs the impact on profit is incredible.
Hi Tesla, For a company that is IP driven I cannot understand the threads on this board focussing on ventilators. It is a very short term, low margin revenue gain - it does help cover fixed costs of equipment but that's about it.
Wish I had done the same. Does look like a traders share, good if you get in and out at the right times within a six month window. Medium term worries that airports / customs business is dead with lower travel volume, and healthcare budgets focused on Covid. Ventilators just short term noise and distraction. Real lack of communication from the company is a major issue, either nothing to report or bod are poor and unnatural communicators - likely a mix of both.
The reason they shouldn't use "modest" is purely because it is relative and open to individual interpretation. I welcome the conservative approach to the rns rather some of the hype you get elsewhere on AIM. In this case it does appear to be a deal which is relatively immaterial in the short term, the good news is that the volume of these individual deals is adding up - a proportion of which will not perform but some that will transform revenue
Some positives, gross margin / cash retention / market coming out of lockdown. Key issue underlying loss excludes - depreciation, amortisation, share-based payments, 2019 PhD acquisition costs and foreign exchange variances on intercompany balance - so a hell of a lot impacting the P&L and share price.
I knew from research they were huge, they actually have their uk offices round the corner from me in marlow. Makes a great deal of sense now from an operational and working capital perspective from ethernity. Also for techtrnics to get involved they must see the value and potential of a sizable piece of business (compared to their billions of revenue), this gives a good deal of comfort.
hi tracy. Was really confused at the time on techtronics as a distributor with their background in fairly simple low level equipment. Now understand if the volume is there at the level you describe this makes sense.
Hi nim. Shareholder for about a year with a 3-5 year timeframe, relatively large holding of 20k shares as one of the few risk shares in my sipp. Recognise the historic p&l and cash burn, and the uncertainty of both timing and value of future revenue streams.
As an emea fd in the saas / software sector ( which has a similar business model) the mix of r&d costs, fixed and variable production costs and s&m overheads are key to the ability to quickly ramp profits at a higher % rate than sales. The major difference to software is s&m costs which scale at a much higher rate than opti.
As you say I may be wrong on owning this share, but the conversation is worthwhile and should have regular 6 month check on progress on this board, something I do mentally with results and communication anyway.